Section
1503,
Pub. L. 100–690, title I, § 1004, Nov. 18, 1988,
102 Stat. 4184, related to coordination between Office of National Drug Control Policy and executive branch departments and agencies. See section
1704 of this title.
Section
1504,
Pub. L. 100–690, title I, § 1005, Nov. 18, 1988,
102 Stat. 4185;
Pub. L. 103–322, title IX, § 90203, Sept. 13, 1994,
108 Stat. 1991;
Pub. L. 105–20, § 2(b), June 27, 1997,
111 Stat. 234, related to annual development and submission of National Drug Control Strategy by President to Congress. See section
1705 of this title.
Section
1505,
Pub. L. 100–690, title I, § 1008, formerly § 1003A, as added
Pub. L. 101–510, div. A, title X, § 1011, Nov. 5, 1990,
104 Stat. 1633; renumbered § 1008 and amended
Pub. L. 103–322, title IX, § 90204(a), (b), (c)(2), (3), Sept. 13, 1994,
108 Stat. 1993, 1994, established Counter-Drug Technology Assessment Center within Office of National Drug Control Policy. See section
1707 of this title.
A prior section
1505,
Pub. L. 100–690, title I, § 1008, Nov. 18, 1988,
102 Stat. 4188, provided for an executive reorganization study and report to Congress and the President no later than Jan. 15, 1990, prior to repeal by
Pub. L. 103–322, § 90204(c)(1).